Diagnos Inc.
TSX VENTURE : ADK

Diagnos Inc.

October 28, 2009 11:26 ET

DIAGNOS Announces Proposed Financing of up to $1,200,000

BROSSARD, QUEBEC--(Marketwire - Oct. 28, 2009) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today a proposed private placement of up to 6,000,000 units ("Units"), issued at $0.20 per Unit, for gross proceeds of up to $1,200,000.

Each Unit would be comprised of one Common Share and one-half of a Common Share purchase warrant (each full warrant, a "Warrant"). Each Warrant would entitle its holder to acquire one Common Share at a price of $0.30 at any time during the 24 months following the initial closing date. The securities to be issued are subject to a 4-month hold period and other requirements set by the TSX Venture Exchange.

This proposed private placement is subject to receipt of all required regulatory approvals, as well as the negotiation and execution of formal documentation.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

  • DIAGNOS Inc.
    Andre Larente - President
    Investor relations representative
    1-877-678-8882 or 450-678-8882, ext. 224
    alarente@diagnos.com